F. H. Al-Musawi, J. (2014). The variation between Angiotensin-Converting Enzyme Inhibitors (A.C.E. Inhibitors) and Angiotensin II Receptors Antagonists (A.II R.A.), in C.O.P.Ds. and Hypertensive patients. Alustath, 8(1), 63-71.
Jawad F. H. Al-Musawi. "The variation between Angiotensin-Converting Enzyme Inhibitors (A.C.E. Inhibitors) and Angiotensin II Receptors Antagonists (A.II R.A.), in C.O.P.Ds. and Hypertensive patients". Alustath, 8, 1, 2014, 63-71.
F. H. Al-Musawi, J. (2014). 'The variation between Angiotensin-Converting Enzyme Inhibitors (A.C.E. Inhibitors) and Angiotensin II Receptors Antagonists (A.II R.A.), in C.O.P.Ds. and Hypertensive patients', Alustath, 8(1), pp. 63-71.
F. H. Al-Musawi, J. The variation between Angiotensin-Converting Enzyme Inhibitors (A.C.E. Inhibitors) and Angiotensin II Receptors Antagonists (A.II R.A.), in C.O.P.Ds. and Hypertensive patients. Alustath, 2014; 8(1): 63-71.

The variation between Angiotensin-Converting Enzyme Inhibitors (A.C.E. Inhibitors) and Angiotensin II Receptors Antagonists (A.II R.A.), in C.O.P.Ds. and Hypertensive patients

Thi-Qar Medical Journal
Article 1, Volume 8, Issue 1, December 2014, Pages 63-71
Author
Jawad F. H. Al-Musawi
Abstract
ABSTRACT
This study reflects that both A.C.E. inhibitors and A.IIR.A. had been reduced the hypertension in a total 281 patients, that A.C.E. inhibitors had significant results 175(62.27%), more than A.IIR.A. 106(27.72%) in treatment of hypertension in those C.O.P.D. patients with ages ranged between (40-70) years old. Also, we found that there was some degree of serum lipids reduction in those patients which were treated by either A.C.E. inhibitors 22(8.185%), or by A.IIR.A.24(8.540%), with no significant different results in this reduction of serum lipids in both A.C.E. inhibitors and A.IIR.A..
Statistics
Article View: 112
PDF Download: 23


Journal Management System. Powered by ejournalplus.com